TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $23,272,000 | -4.9% | 221,071 | -0.2% | 0.00% | -25.0% |
| Q3 2016 | $24,481,000 | -20.9% | 221,529 | +4.2% | 0.00% | -20.0% |
| Q2 2016 | $30,942,000 | +104.4% | 212,517 | +101.1% | 0.01% | +150.0% |
| Q1 2016 | $15,136,000 | -0.7% | 105,661 | +7.2% | 0.00% | -33.3% |
| Q4 2015 | $15,237,000 | +2965.8% | 98,591 | +2737.2% | 0.00% | – |
| Q3 2015 | $497,000 | -74.8% | 3,475 | -74.6% | 0.00% | – |
| Q2 2015 | $1,969,000 | -12.0% | 13,703 | -13.6% | 0.00% | – |
| Q1 2015 | $2,237,000 | +23.6% | 15,865 | +29.9% | 0.00% | – |
| Q4 2014 | $1,810,000 | +469.2% | 12,216 | +490.7% | 0.00% | – |
| Q3 2014 | $318,000 | -81.5% | 2,068 | -83.1% | 0.00% | – |
| Q2 2014 | $1,719,000 | +40.0% | 12,254 | +10.8% | 0.00% | – |
| Q1 2014 | $1,228,000 | +0.5% | 11,064 | -10.5% | 0.00% | – |
| Q4 2013 | $1,222,000 | +5.5% | 12,359 | -18.9% | 0.00% | – |
| Q3 2013 | $1,158,000 | +15.6% | 15,242 | -15.0% | 0.00% | – |
| Q2 2013 | $1,002,000 | – | 17,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |